Michael H. Mulroy Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael H. Mulroy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael H. Mulroy. Michael H. Mulroy is Director in BIOTIME INC ($BTX) and EVP, CFO & General Counsel in QUESTCOR PHARMACEUTICALS INC ($QSC) and See Remarks in QUESTCOR PHARMACEUTICALS INC ($QSC) and Sr VP, CFO & General Counsel in QUESTCOR PHARMACEUTICALS INC ($QSC) and President and CEO in Asterias Biotherapeutics, Inc. ($ASTY) and Director in AgeX Therapeutics, Inc. ($AGE).
Latest Insider Trading Transactions of Michael H. Mulroy
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGE, ASTY, BTX, QSC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 02 2020 | BTX | Lineage Cell Thera ... | Mulroy Michael H. | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Mar 15 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Grant | A | 0.00 | 194,271 | 0 | 226,821 | 32.6 K to 226.8 K (+596.84 %) |
| Mar 15 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Grant | A | 0.00 | 194,271 | 0 | 226,821 | 32.6 K to 226.8 K (+596.84 %) |
| Mar 13 2019 | AGE | AgeX Therapeutics, ... | Mulroy Michael H. | Director | Option Exercise | A | 4.28 | 65,000 | 278,200 | 65,000 | |
| Mar 05 2019 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Payment of Exercise | F | 0.95 | 76,588 | 72,759 | 273,622 | 350.2 K to 273.6 K (-21.87 %) |
| Mar 05 2019 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Grant | A | 0.00 | 252,606 | 0 | 350,210 | 97.6 K to 350.2 K (+258.81 %) |
| Aug 29 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.59 | 3,141 | 5,000 | 97,604 | 94.5 K to 97.6 K (+3.33 %) |
| Jul 27 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.69 | 2,950 | 5,000 | 94,463 | 91.5 K to 94.5 K (+3.22 %) |
| Jul 03 2018 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| Jun 27 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.63 | 3,067 | 4,999 | 91,513 | 88.4 K to 91.5 K (+3.47 %) |
| May 31 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.59 | 3,153 | 5,000 | 88,446 | 85.3 K to 88.4 K (+3.70 %) |
| Apr 27 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.33 | 3,752 | 4,990 | 85,293 | 81.5 K to 85.3 K (+4.60 %) |
| Mar 28 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.76 | 2,839 | 4,997 | 81,541 | 78.7 K to 81.5 K (+3.61 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Option Exercise | A | 1.95 | 200,000 | 390,000 | 200,000 | |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Payment of Exercise | F | 1.95 | 28,358 | 55,298 | 78,702 | 107.1 K to 78.7 K (-26.49 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Grant | A | 0.00 | 94,872 | 0 | 107,060 | 12.2 K to 107.1 K (+778.40 %) |
| Feb 28 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.22 | 2,255 | 5,000 | 12,188 | 9.9 K to 12.2 K (+22.70 %) |
| Jan 26 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.34 | 2,134 | 5,000 | 9,933 | 7.8 K to 9.9 K (+27.36 %) |
| Dec 28 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.22 | 2,247 | 4,988 | 7,799 | 5.6 K to 7.8 K (+40.47 %) |
| Nov 29 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.41 | 2,076 | 5,003 | 5,552 | 3.5 K to 5.6 K (+59.72 %) |
| Oct 27 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.55 | 1,939 | 4,944 | 3,476 | 1.5 K to 3.5 K (+126.15 %) |
| Sep 27 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 3.25 | 1,537 | 4,997 | 1,537 | 0 to 1.5 K |
| Jul 05 2017 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Option Exercise | A | 3.15 | 20,000 | 63,000 | 20,000 | |
| Jun 28 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Option Exercise | A | 3.70 | 800,000 | 2,960,000 | 800,000 | |
| Jul 05 2016 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Option Exercise | A | 2.72 | 20,000 | 54,400 | 20,000 | |
| Jul 06 2015 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Option Exercise | A | 3.57 | 20,000 | 71,400 | 20,000 | |
| Aug 04 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Payment of Exercise | F | 92.35 | 1,304 | 120,424 | 75,759 | 77.1 K to 75.8 K (-1.69 %) |
| Jul 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Option Exercise | M | 14.24 | 10,000 | 142,400 | 75,000 | |
| Jul 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 90.86 | 5,000 | 454,325 | 77,063 | 82.1 K to 77.1 K (-6.09 %) |
| Jul 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 90.92 | 5,000 | 454,588 | 82,063 | 87.1 K to 82.1 K (-5.74 %) |
| Jul 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Buy | M | 14.24 | 10,000 | 142,400 | 87,063 | 77.1 K to 87.1 K (+12.98 %) |
| Jun 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Option Exercise | M | 14.24 | 10,000 | 142,400 | 85,000 | |
| Jun 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 88.58 | 5,000 | 442,876 | 77,063 | 82.1 K to 77.1 K (-6.09 %) |
| Jun 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 88.57 | 5,000 | 442,869 | 82,063 | 87.1 K to 82.1 K (-5.74 %) |
| Jun 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Buy | M | 14.24 | 10,000 | 142,400 | 87,063 | 77.1 K to 87.1 K (+12.98 %) |
| May 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Option Exercise | M | 14.24 | 10,000 | 142,400 | 95,000 | |
| May 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 87.97 | 5,000 | 439,857 | 77,063 | 82.1 K to 77.1 K (-6.09 %) |
| May 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 88.01 | 5,000 | 440,052 | 82,063 | 87.1 K to 82.1 K (-5.74 %) |
| May 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Buy | M | 14.24 | 10,000 | 142,400 | 87,063 | 77.1 K to 87.1 K (+12.98 %) |
| Apr 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Option Exercise | M | 14.24 | 10,000 | 142,400 | 105,000 | |
| Apr 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 85.03 | 5,000 | 425,155 | 77,063 | 82.1 K to 77.1 K (-6.09 %) |
| Apr 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 85.05 | 5,000 | 425,245 | 82,063 | 87.1 K to 82.1 K (-5.74 %) |
| Apr 14 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Buy | M | 14.24 | 10,000 | 142,400 | 87,063 | 77.1 K to 87.1 K (+12.98 %) |
| Mar 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Option Exercise | M | 14.24 | 10,000 | 142,400 | 115,000 | |
| Mar 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 65.59 | 2,253 | 147,776 | 77,063 | 79.3 K to 77.1 K (-2.84 %) |
| Mar 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 65.07 | 4,390 | 285,653 | 79,316 | 83.7 K to 79.3 K (-5.24 %) |
| Mar 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | S | 63.91 | 3,357 | 214,561 | 83,706 | 87.1 K to 83.7 K (-3.86 %) |
| Mar 12 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Buy | M | 14.24 | 10,000 | 142,400 | 87,063 | 77.1 K to 87.1 K (+12.98 %) |
| Feb 26 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Payment of Exercise | F | 79.46 | 12,552 | 997,382 | 77,063 | 89.6 K to 77.1 K (-14.01 %) |
| Feb 26 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Sell | D | 0.00 | 12,167 | 0 | 89,615 | 101.8 K to 89.6 K (-11.95 %) |
| Feb 26 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 101,782 | 83.8 K to 101.8 K (+21.48 %) |
| Feb 26 2014 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 83,782 | 65.8 K to 83.8 K (+27.36 %) |
| Aug 02 2013 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | EVP, CFO & General ... | Grant | A | 0.00 | 10,000 | 0 | 65,782 | 55.8 K to 65.8 K (+17.93 %) |
| Feb 26 2013 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | Sr VP, CFO & Genera ... | Grant | A | 0.00 | 18,250 | 0 | 54,260 | 36 K to 54.3 K (+50.68 %) |
| Feb 26 2013 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | Sr VP, CFO & Genera ... | Grant | A | 0.00 | 18,250 | 0 | 36,010 | 17.8 K to 36 K (+102.76 %) |
| Feb 26 2013 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | Sr VP, CFO & Genera ... | Grant | A | 0.00 | 15,643 | 0 | 17,760 | 2.1 K to 17.8 K (+738.92 %) |
| May 24 2012 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | Sr VP, CFO & Genera ... | Buy | P | 40.00 | 1,000 | 40,000 | 2,117 | 1.1 K to 2.1 K (+89.53 %) |
| Feb 17 2012 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | Sr VP, CFO & Genera ... | Option Exercise | A | 35.78 | 20,000 | 715,600 | 20,000 | |
| Feb 17 2012 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | Sr VP, CFO & Genera ... | Option Exercise | A | 35.78 | 60,000 | 2,146,800 | 60,000 | |
| Feb 18 2011 | QSC | QUESTCOR PHARMACEU ... | Mulroy Michael H. | Sr VP, CFO & Genera ... | Option Exercise | A | 14.24 | 125,000 | 1,780,000 | 125,000 |
Page: 1